Pierre Feugier

Summary

Affiliation: CHU de Nancy
Country: France

Publications

  1. ncbi request reprint [Chronic lymphoid leukemia and intravenous immunoglobulins]
    P Feugier
    Service d hématologie adulte, CHU Brabois, Allee du Morvan, 54511 Vandoeuvre, France
    Rev Med Interne 28:2-4. 2007
  2. ncbi request reprint [Multiple myeloma and intravenous immunoglobulins]
    P Feugier
    Service d hématologie adulte, CHU Brabois, Allee du Morvan, 54511 Vandoeuvre, France
    Rev Med Interne 28:5-6. 2007
  3. ncbi request reprint [Secondary deficiencies of humoral immunity in hematology: what management?]
    P Feugier
    Service d hématologie adulte, CHU Brabois, Allee du Morvan, 54511 Vandoeuvre, France
    Rev Med Interne 28:1. 2007
  4. ncbi request reprint Osteopetrotic mouse stroma with thrombopoietin, c-kit ligand, and flk-2 ligand supports long-term mobilized CD34+ hematopoiesis in vitro
    Pierre Feugier
    James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Stem Cells Dev 14:505-16. 2005
  5. ncbi request reprint [Criteria of the eligibility of patients for treatment with intravenous normal human immunoglobulin]
    P Feugier
    Service d hématologie adulte, CHU Brabois, Allee du Morvan, 54511 Vandoeuvre, France
    Rev Med Interne 28:7-9. 2007
  6. ncbi request reprint Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cells
    Pierre Feugier
    Department of Hematology, University Hospital, Nancy, France
    Transfusion 43:878-84. 2003
  7. ncbi request reprint Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte
    P Feugier
    Hematology Department, Centre Hospitalier Universitaire de Brabois, 54500 Vandoeuvre les Nancy, France
    J Clin Oncol 23:4117-26. 2005
  8. ncbi request reprint Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab
    P Feugier
    Service hématologie, Service Informatique Médicale, Hopitaux de Brabois, Nancy, France
    Ann Oncol 15:129-33. 2004
  9. ncbi request reprint Ex vivo expansion of stem and progenitor cells in co-culture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin, c-kit ligand, and Flt-3 ligand
    Pierre Feugier
    James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 101, New York, NY 10021, USA
    J Hematother Stem Cell Res 11:127-38. 2002
  10. ncbi request reprint Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity
    Na Li
    Laboratoire d Ingénierie et de Thérapie Cellulaire et Tissulaire, Faculte de Medecine, Universite Henri Poincare, Nancy, France
    Exp Hematol 35:507-15. 2007

Collaborators

Detail Information

Publications23

  1. ncbi request reprint [Chronic lymphoid leukemia and intravenous immunoglobulins]
    P Feugier
    Service d hématologie adulte, CHU Brabois, Allee du Morvan, 54511 Vandoeuvre, France
    Rev Med Interne 28:2-4. 2007
  2. ncbi request reprint [Multiple myeloma and intravenous immunoglobulins]
    P Feugier
    Service d hématologie adulte, CHU Brabois, Allee du Morvan, 54511 Vandoeuvre, France
    Rev Med Interne 28:5-6. 2007
  3. ncbi request reprint [Secondary deficiencies of humoral immunity in hematology: what management?]
    P Feugier
    Service d hématologie adulte, CHU Brabois, Allee du Morvan, 54511 Vandoeuvre, France
    Rev Med Interne 28:1. 2007
  4. ncbi request reprint Osteopetrotic mouse stroma with thrombopoietin, c-kit ligand, and flk-2 ligand supports long-term mobilized CD34+ hematopoiesis in vitro
    Pierre Feugier
    James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Stem Cells Dev 14:505-16. 2005
    ....
  5. ncbi request reprint [Criteria of the eligibility of patients for treatment with intravenous normal human immunoglobulin]
    P Feugier
    Service d hématologie adulte, CHU Brabois, Allee du Morvan, 54511 Vandoeuvre, France
    Rev Med Interne 28:7-9. 2007
  6. ncbi request reprint Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cells
    Pierre Feugier
    Department of Hematology, University Hospital, Nancy, France
    Transfusion 43:878-84. 2003
    ..It is not clear whether the quantification of CFU-GM and CD34+ cells should be done on fresh components and after cryopreservation, which better represents the actual composition of the graft...
  7. ncbi request reprint Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte
    P Feugier
    Hematology Department, Centre Hospitalier Universitaire de Brabois, 54500 Vandoeuvre les Nancy, France
    J Clin Oncol 23:4117-26. 2005
    ....
  8. ncbi request reprint Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab
    P Feugier
    Service hématologie, Service Informatique Médicale, Hopitaux de Brabois, Nancy, France
    Ann Oncol 15:129-33. 2004
    ..The addition of rituximab increases the complete response rate and prolongs event-free and overall survival in elderly patients with such lymphoma...
  9. ncbi request reprint Ex vivo expansion of stem and progenitor cells in co-culture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin, c-kit ligand, and Flt-3 ligand
    Pierre Feugier
    James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 101, New York, NY 10021, USA
    J Hematother Stem Cell Res 11:127-38. 2002
    ....
  10. ncbi request reprint Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity
    Na Li
    Laboratoire d Ingénierie et de Thérapie Cellulaire et Tissulaire, Faculte de Medecine, Universite Henri Poincare, Nancy, France
    Exp Hematol 35:507-15. 2007
    ..Recently, MSC have been demonstrated to improve expansion of cord blood heamtopoietic stem cells (HSC)...
  11. doi request reprint Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adult
    Franck Morschhauser
    Hematology Department, Lille University Hospital Center, Lille, France
    Cancer 116:4299-308. 2010
    ....
  12. ncbi request reprint Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host disease
    Pierre Bordigoni
    Blood and Marrow Transplantation unit Department of Pediatric Onco Hematology, Hôpital d Enfants, rue du Morvan, Vandoeuvre les Nancy, France
    Br J Haematol 135:382-5. 2006
    ..Daclizumab could be a suitable alternative treatment for aGVHD, particularly when limited to the skin or gastrointestinal tract...
  13. doi request reprint Polymorphonuclear neutrophils from JAK2(V617F) positive MPD patients do not support hypercoagulability: A study with calibrated automated thrombography (CAT)
    Julien Perrin
    CHU Nancy, Service d Hematologie Biologique, pôle laboratoires, Nancy, France
    Blood Cells Mol Dis 46:235-8. 2011
    ..The presence of an active protein C pathway or platelets might provide a better insight into the coagulation phenotype in MPD...
  14. ncbi request reprint Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients
    Jean Pierre Bronowicki
    Department of Hépato gastroentérologie, INSERM EMI 0014, CHU, Nancy
    Hepatology 37:781-7. 2003
    ..Most of the HCV-infected patients presented a high-grade, B-cell type lymphoma. In conclusion, our study confirms the rarity of PLL and demonstrates an increased prevalence of HCV infection...
  15. ncbi request reprint [Evaluation of a telemedicine system for the transmission of morpho/immunological data at the inclusion of patients in a therapeutic trial (Goelams LLC 98)]
    J F Lesesve
    Services d hématologie clinique et biologique, CHU de Nancy
    Ann Biol Clin (Paris) 65:143-52. 2007
    ..The limiting factors were the personal investment of the experts, but mainly the implication of first line morphologists which should benefit from adequate tools to apprehend this system of second reading like a quality control...
  16. ncbi request reprint T-cell immune constitution after peripheral blood mononuclear cell transplantation in complete DiGeorge syndrome
    Daniele Bensoussan
    Unité de Thérapie cellulaire et Tissus, CHU de Nancy, UMR CNRS 7563, Allee du Morvan, 54511 Vandoeuvre les Nancy, France
    Br J Haematol 117:899-906. 2002
    ..After immunizations, specific antibodies were produced. PBMCT from an HLA identical sibling could be an efficient treatment of immune deficiency in cDGS...
  17. ncbi request reprint Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extend
    Pierre Feugier
    Hematologie, Hopitaux de Brabois, Nancy, France
    Blood 104:2675-81. 2004
    ..This study demonstrated that LPHL and cHL without MI shared the same presenting characteristics and the same excellent long-term prognosis after a brief anthracycline-based chemotherapy plus high-dose extended irradiation...
  18. ncbi request reprint [Granulocyte sarcoma of the pancreas without extra-pancreatic location]
    S Dimicoli
    Service d hématologie et de médecine interne, CHU Nancy Brabois, Allee du Morvan, 54511 Vandoeuvre
    Presse Med 31:1024-6. 2002
    ..The pancreatic location and recurrence, aside from any context of malignant hemopathy, are exceptional...
  19. doi request reprint Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study
    Catherine Sebban
    Centre Leon Berard, Lyon, France
    J Clin Oncol 26:3614-20. 2008
    ..The effect of these two strategies on the outcome of relapsing patients with follicular lymphoma has never been compared...
  20. ncbi request reprint Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de
    Catherine Sebban
    Centre Leon Berard, 28 rue Laennec, 69008 Lyon, France
    Blood 108:2540-4. 2006
    ..After long-term follow-up, our study showed that there was no statistically significant benefit in favor of first-line high-dose therapy in patients with follicular lymphoma. High-dose therapy should be reserved for relapsing patients...
  21. ncbi request reprint Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia
    Olivier Tournilhac
    Service d Hematologie Clinique, Hotel Dieu, Centre Hospitalier Universitaire, Clermont Ferrand, Paris, France
    Blood 103:363-5. 2004
    ..0 x 106/kg or more CD34 cells were collected in only 12. Explorations of the mechanism of poor mobilization and adaptation of PBSC harvest policies after fludarabine treatment are therefore warranted...
  22. ncbi request reprint Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells
    Cindy Grandjenette
    Haematologica 92:1279-81. 2007
    ..Furthermore, TLR7 and TLR9 appear to be functional and liable to respond to specific ligands, respectively imidazoquinolines and CpG-ODN thus potentially opening new therapeutic approaches...
  23. ncbi request reprint [An uncommon and misleading neoplasm to know!]
    Guillaume Granier
    Service d Anatomie et de Cytologie Pathologiques, Allee du Morvan, CHU de Nancy, 54511 Vandooevre les Nancy
    Ann Pathol 23:283-4. 2003